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Purpose: All current international clinical guidelines recommend
conservative non-pharmacological treatments, such as physical ther-
apy, for hip osteoarthritis (OA). Physical therapy for hip OA is typically
multimodal, with exercise, manual therapy, education/advice, and gait
aids routinely employed worldwide. While there is limited support for
some individual components, namely exercise and manual therapy,
evidence about the efﬁcacy of physical therapy management is incon-
clusive due to the lack of quality studies. Given the substantial con-
tribution of both the placebo effect and the beneﬁts associated with
therapist contact during OA treatment, inclusion of a sham physical
therapy control group would enable the impact of active physical
therapy to be more accurately evaluated in such trials. Therefore, the
primary aim of this study was to evaluate whether a 12-week multi-
modal physical therapy program, with components typical of interna-
tional clinical practice, leads to greater improvements in pain and
physical function compared to sham physical therapy.
Methods: In a randomized, assessor- and participant-blinded, placebo-
controlled trial, volunteers with hip osteoarthritis were randomly
assigned to receive either active or sham physical therapy. All partic-
ipants received ten treatment sessions over 12 weeks with a physical
therapist. Active treatment comprised a semi-standardized multimodal
program including education/advice, manual therapy, home exercise
and, if appropriate, provision of a gait aid. Sham treatment comprised
inactive ultrasound and application of inert gel to the hip region. During
the 24 weeks following treatment, the active group continued unsu-
pervised home exercise while the sham group self-applied gel three
times weekly. Primary outcomes were average overall pain using a
visual analogue scale (0-100 mm) and physical function (0-68), meas-
ured using the Western Ontario and McMaster Universities Osteo-
arthritis Index (WOMAC) at 13 and 36 following the completion of
treatment. Secondary outcomes assessed physical impairments, phys-
ical performance, psychological status, quality-of-life and cost effec-
tiveness. Statistical analyses were performed on an intention-to-treat
basis using all randomized participants.
Results: One hundred and two participants were enrolled and 96 (94%)
and 83 (81%) completed the week 13 and 36 follow-up measurements
respectively. Baseline characteristics were similar between the two
groups. There were no signiﬁcant between-group differences in change
in VAS pain (48 mm, 95% CI -46 to 143, p¼032) or WOMAC physical
function (07 units, 95% CI -39 to 53, p¼077) at the 13 or 36 week
time points. Observed between-group differences were smaller than
the minimal clinically important differences, and the 95% conﬁdence
intervals indicated that the ranges of plausible between-group differ-
ences were unlikely to have included differences of any practical
importance. Both groups showed signiﬁcant and similar within-group
improvements in pain and physical function at both time points. There
were no between-group differences for changes in all except two sec-
ondary outcomes.
Conclusions: We found that a 12-week multimodal physical therapy
treatment for hip OA, with components typical of current internationalDose response of weight change with the change in pain and function in study popula
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* Data is presented as regression coefﬁcients (B) with conﬁdence intervals (CI). Change in K
for age, gender, baseline weight, height and KOOS measures.
* Category of weight loss of <2.5 was entered as a reference variable.clinical practice, did not confer additional beneﬁts for hip pain or
function over a realistic sham treatment that controlled for therapist
contact time, therapeutic environment and home treatment. However,
both groups did show signiﬁcant and clinically relevant within-group
improvements following treatment. Given that hip OA patients not
undergoing treatment show little improvements over similar time
frames, the lack of between group differences in our study most likely
reﬂects a large placebo and/or treatment effect from the therapeutic
relationship between the physical therapist and the patient.
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Purpose: It has been established that weight reduction has the ability to
decrease pain and disability in knee osteoarthritis (OA). A greater
weight reduction is likely to cause incremental improvement in
symptoms and function by reducing joint loading but has not been
previously investigated. Therefore, this study examined the dose-
response relationship between the magnitude of weight reduction and
improvement in pain and functional outcome.
Methods: Consecutive participants with knee OA enrolled in a weight
loss programme, “Healthy weight for life” were selected. All partic-
ipants fulﬁlled the American College of Rheumatologists criteria for
classiﬁcation of knee osteoarthritis. This program is a structured
remotely delivered 18 week knee and hip OA disease management
program that systematically integrates intensive weight loss as part of
its tailored interventions. This programme was conducted with the aim
of a 7-10% loss of body weight by dietary intervention over 18 weeks.
The participants were provided online and written healthy eating
advice and lifestyle education and tools together with targeted tele-
phone motivation and support. The dietary habits were changed over 3
phases: phase 1 - motivational weight loss utilizing low calorie diet
meal replacement, with controlled portions, and free foods for 6 weeks;
phase 2 - consolidation weight loss for 6 weeks and phase 3 -short term
weight maintenance. All participants in this cohort received the same
strength / balance / mobility exercise tools, instruction, support and
encouragement
All participants were assessed at baseline, 6 weeks and 18 weeks for
body weight and Knee Injury and Osteoarthritis Outcome Score (KOOS).
The dose-response relationship between weight-change category
(>10%, 7.6-10%, 5.1-7.5%, 2.5-5.0% and <2.5% weight loss) and change in
the KOOS scores was assessed using repeated measures ANCOVA and
controlled for baseline age, BMI, baseline KOOS and gender. The weight
loss categories were based on the IDEA trial goal (10%), the weight loss
goal of the diet groups in the ADAPT study (5%) and the weight loss
typically achieved in an exercise only cohort of older adults with knee
OA (<5%).tion
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.7) 0.667 2.3 (-3.6-8.3) 0.443 4.0 (-0.45-8.4) 0.078
0 0
OOS factors were entered as dependent variables. Regressionmodels were adjusted
Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56 S51Results: 1383 (70.9% females) persons were enrolled in this study.
Mean age, height and weight was 64 years (SD 8.7), 1.66m (SD 0.09)
and 95.12 kg (SD  17.2) respectively. The mean body mass index (BMI)
was 34.4 (SD  5.2) with 81.7% of participants being obese at baseline.
Themean KOOS pain and function scores were 56.3 (SD 16.8) and 59.5
(SD  18.3) respectively at baseline.
1303 (94.2%) of participants had a >2.5% reduction in body weight.
The number (%) of participants according to percentage weight loss
categories were as follows:less than 2.5% ¼79 (5.7%); 2.6-5%¼223
(16.1%), 5.1-7.5% ¼332 (24.0%); 7.6-10% ¼ 317 (22.9%) and >10% ¼
431(31.2%). Participants in weight loss categories did not differ on
gender, age or baseline KOOS measures. There was a signiﬁcant dose-
response relationship to percentage of weight change across all
weight change categories. The dose-response relationship was seen
in all KOOS scores assessed, namely pain, function, symptoms, sport
and recreation and quality of life scores on regression analysis. The
group with the largest amount of weight loss (10%) showed the
most improvement in the pain, function and all the other charac-
teristics assessed (Table 1). The non-weight loss interventions (eg.
strength / balance / mobility exercise, personal support, pain man-
agement strategies etc.) were consistent across the cohort and would
have also contributed to the improvement seen in the low weight
loss group
Conclusions: There is a strong dose response relationship between the
percentage weight loss and the improvement in knee pain, function,
symptoms, sport/recreation and quality of life. The approximately 40%
improvement in symptoms in those losing 10% of their body weight is
consistent with the recent pivotal IDEA trial. This study conﬁrms the
dose-response beneﬁt of weight loss as a therapeutic intervention in
knee osteoarthritis and demonstrates the effectiveness of disseminat-
ing and implementing a weight loss intervention in a community based
setting
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Purpose: To determine whether land-based therapeutic exercise is
beneﬁcial for people with hip OA in terms of reduced joint pain and
improved physical function or quality of life.
Methods: A systematic review and meta-analysis. Five databases were
searched from inception up until February 2013. All randomised con-
trolled trials (RCTs) recruiting people with hip OA and comparing some
form of land-based therapeutic exercise (as opposed to exercises con-
ducted in the water) with a non-exercise group were included. Pro-
grammes could be designed and supervised by physiotherapists or
other professionals, or provided as a home program with minimal
monitoring. Pre-surgery (total hip replacement) programs were exclu-
ded. The comparator could be active (any non-exercise intervention) or
placebo (no treatment or waiting list) group. Studies that compared one
type of exercise programme to another exercise programme, provided
an exercise programme to all treatment allocations (and evaluated the
added beneﬁt of an electrophysical agent or hydrotherapy), compared
exercise with manual therapy and those comparing programmes of
varying intensities, were excluded.
Four reviewers independently selected studies for inclusion. Disagree-
ments were resolved through consensus. Two reviewers independently
extracted data and assessed methodological quality. All analyses were
conducted on continuous outcomes. Results were pooled using stand-
ardised mean differences (SMD) to calculate treatment effect sizes from
the end of treatment scores and related standard deviation (SD) scores,
where possible. Outcomes pooled using SMD were re-expressed as
absolute mean difference using a representative control group (high
weighting in pooled analyses) baseline SD.
Results: A total of ten RCTs were identiﬁed, seven considered to dem-
onstrate a low risk of bias. One of the ten RCTs was only reported as a
conference abstract and did not provide sufﬁcient data for the evalua-
tion of bias risk.
High quality evidence from nine trials (549 participants) indicated
exercise reduces pain (SMD -0.38, 95% CI -0.20 to-0.55) and improves
physical function (SMD -0.38, 95% CI -0.05 to -0.54) immediately aftertreatment. Pain and physical function was estimated to be 40 points on
a 0 to 100 point scale (0 is no pain or loss of physical function) in the
control group; exercise reduced pain by an equivalent of 8 points (4 to
11 points) and improved physical function by an equivalent to 7 points
(1 to 12 points).
The reduction in pain was sustained at least three to six months after
ceasing monitored treatment (ﬁve RCTs, 391 participants): pain (SMD
-0.38, 95% CI -0.18 to -0.58). This translates to a sustained reduction in
pain intensity of 8 points (4 to 12 points) compared to the control group
(0 to 100 scale). The improvement in physical function was also sus-
tained (ﬁve RCTs, 367 participants): physical function (SMD -0.37, 95%
CI -0.16 to -0.57) which translates to a mean improvement of 7 (4 to 13)
points compared to the control group.
There was limited evidence from three studies (183 participants) of no
beneﬁt of exercise in terms of quality of life (SMD -0.10, 95% CI 0.19 to
-0.40).
Only ﬁve of the ten RCTs exclusively recruited people with symptomatic
hip OA (419 participants). There was no signiﬁcant difference in pain or
physical function outcomes compared with ﬁve studies recruiting par-
ticipants with hip or knee OA (130 participants).
Conclusions: Pooling the results of these nine RCTs demonstrated
that land-based therapeutic exercise programs can reduce pain and
improve physical function among people with symptomatic hip
osteoarthritis.
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Purpose: There is evidence supporting the effectiveness of both
exercise therapy and manual therapy for hip and knee osteoarthritis
(OA), but few clinical trials report their incremental effectiveness
compared with usual medical care, and most report only short-term
follow-up.
Methods: This was a randomized controlled trial with 2-year follow-up.
Adults meeting the American College of Rheumatology criteria for hip
or knee OA were randomly allocated to receive the following inter-
ventions in addition to usual care: a] exercise therapy; b] manual
therapy; c] combined exercise therapy and manual therapy; or d] no
trial intervention (i.e. usual medical care only). Groups a-c were pro-
vided 10 treatment sessions, including 7 sessions in the ﬁrst 9 weeks,
plus 2 booster sessions at 4 months and 1 at 13 months. Participants
were reassessed at 2 years, blind to group allocation. We report treat-
ment effects on the Western Ontario and McMaster (WOMAC) osteo-
arthritis index (24 questions, 0-10 scale, total range 0-240), quality-
adjusted life years, and physical performance measures (timed up-and-
go, 40m fast-paced walk, 30 second sit-to-stand).
Results: Of 206 participants recruited, 186 (90.3%) were retained at 2
years follow-up. Mean age at baseline was 66 years (range 37 to 92), and
mean WOMAC was 100.8 (SD 53.8). Missing data were replaced using
multiple imputation. Intention-to-treat analysis of covariance
(ANCOVA) showed WOMAC score changes at 2 years were superior for
all three intervention groups compared with the usual care group (2-
sided p<0.05). Participants receiving exercise therapy in addition to
usual care showed gains of 31.7 WOMAC points (95% CI 10.0, 53.3), for
an effect size of 0.57 (Cohen’s d; 95% CI.17, .97). Gains for participants
receiving manual therapy were 30.1 (8.9, 51.3) for an effect size of 0.55
(.16, .94). Gains for participants receiving combined exercise therapy
and manual therapy in addition to usual care did not meet our a priori
threshold for clinical signiﬁcance, at 26.2 (6.1, 46.3) WOMAC points, but
did result in a clinically signiﬁcant effect size of 0.52 (.11, .91). Exercise
therapy in addition to usual care resulted in signiﬁcant QALY gains
comparedwith usual care only (.05 QALYs, p¼.002), but manual therapy
or combined therapy did not (both p>.05). The exercise therapy group
showed greater mean changes on most physical performance tests than
did the other groups.
Conclusions: Both exercise physiotherapy and manual physiotherapy
provided incremental beneﬁt over usual care alone at 2 years follow-up.
QALY gains and physical performance test outcomes signiﬁcantly fav-
oured the exercise therapy group.
